Implementer and recipient perspectives of community-wide mass drug administration for soil-transmitted helminths in Kwale County, Kenya.
Adolescent
Adult
Aged
Aged, 80 and over
Animals
Anthelmintics
/ therapeutic use
Communicable Disease Control
/ organization & administration
Disease Eradication
/ organization & administration
Disease Transmission, Infectious
/ prevention & control
Female
Helminthiasis
/ drug therapy
Humans
Interviews as Topic
Kenya
Male
Mass Drug Administration
/ methods
Middle Aged
Neglected Diseases
/ drug therapy
Treatment Outcome
Young Adult
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
29
10
2019
accepted:
27
03
2020
revised:
30
04
2020
pubmed:
21
4
2020
medline:
1
7
2020
entrez:
21
4
2020
Statut:
epublish
Résumé
Soil-transmitted helminthiases (STH) are one of 17 neglected tropical diseases (NTDs) earmarked for control or elimination by 2020 in the WHO's Roadmap on NTDs. Deworming programs for STH have thus far been focused on treating pre-school and school-aged children; however, there is a growing consensus that to achieve elimination of STH transmission, programs must also target adults, potentially through community-wide mass drug administration (MDA). There is currently a gap in the literature on what components are required to deliver community-wide MDA for STH in order to achieve high intervention reach and uptake. Nested within the TUMIKIA Project, a cluster randomized trial in Kenya evaluating the effectiveness of school-based deworming versus community-wide MDA, we collected qualitative data from program implementers and recipients in eight clusters where community-wide MDA was delivered. Data collection included semi-structured in-depth interviews (n = 72) and focus group discussions (n = 32). A conceptual framework for drug distribution was constructed to help build an analysis codebook. Case memos were developed for each top-level theme. Community-wide MDA for STH was perceived as a complex intervention with key administrative and social mobilization domains. Key actionable themes included: (1) developing an efficient strategy to allocate reasonable workload for implementers to cover all targeted households; (2) maximizing community drug distributors' motivation through promoting belief in the effectiveness of the intervention and providing sufficient financial incentives; (3) developing effective capacity building strategies for implementers; and (4) implementing a context-adapted community engagement strategy that leverages existing community structures and takes into consideration past community experiences of MDAs. Transitioning from STH control to elimination goals requires significant planning and action to ensure community-wide MDA is delivered with sufficient reach and uptake. We present findings that can inform national deworming programs to increase intervention delivery capacity.
Identifiants
pubmed: 32310966
doi: 10.1371/journal.pntd.0008258
pii: PNTD-D-19-01749
pmc: PMC7192516
doi:
Substances chimiques
Anthelmintics
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008258Subventions
Organisme : Medical Research Council
ID : MR/N00597X/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107742/Z/15/Z
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS Negl Trop Dis. 2015 Aug 20;9(8):e0003897
pubmed: 26291538
Parasit Vectors. 2010 Aug 11;3:70
pubmed: 20701744
PLoS Negl Trop Dis. 2012;6(9):e1825
pubmed: 23029586
Adv Parasitol. 2019;103:117-149
pubmed: 30878056
BMJ Open. 2015 Oct 19;5(10):e008950
pubmed: 26482774
PLoS Negl Trop Dis. 2018 May 3;12(5):e0006389
pubmed: 29723193
PLoS Negl Trop Dis. 2017 Dec 6;11(12):e0006065
pubmed: 29211746
Parasit Vectors. 2008 May 27;1(1):14
pubmed: 18505577
Parasit Vectors. 2015 Oct 22;8:551
pubmed: 26490544
PLoS Negl Trop Dis. 2015 Mar 23;9(3):e0003610
pubmed: 25799168
J Biosoc Sci. 2016 Jan;48(1):94-112
pubmed: 25790081
Res Rep Trop Med. 2018 Mar 06;9:25-33
pubmed: 30050352
Br J Health Psychol. 2018 Sep;23(3):519-531
pubmed: 29453791
Trop Med Infect Dis. 2018 Nov 21;3(4):
pubmed: 30469342
Lancet. 2019 May 18;393(10185):2039-2050
pubmed: 31006575
J Nurs Scholarsh. 2015 Jan;47(1):96-104
pubmed: 25565278
Am J Trop Med Hyg. 2012 Dec;87(6):1065-72
pubmed: 23091190
Int J Infect Dis. 2018 Jan;66:14-21
pubmed: 29128644
PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2447
pubmed: 24278486
PLoS Negl Trop Dis. 2019 Aug 9;13(8):e0007427
pubmed: 31398204
Malar J. 2014 Feb 04;13:47
pubmed: 24495715
Curr Opin Infect Dis. 2012 Oct;25(5):584-9
pubmed: 22903231
PLoS One. 2014 Jan 14;9(1):e83413
pubmed: 24454703
PLoS One. 2012;7(11):e48395
pubmed: 23185256
SAGE Open Med. 2015 Jul 08;3:2050312115594083
pubmed: 26770791
Afr J Health Sci. 2006 Jan-Jun;13(1-2):69-79
pubmed: 17348745